EAN: 9781626235137

Bilder-Quelle: discount24.de - Sport-Freizeit

Lung cancer is the leading cause of cancer-related death among men and women in the U.S. and worldwide. For many decades lung cancer was the sole cancer among the deadly four without an evidence-based screening method for decreasing mortality. This changed in November 2011 when findings from the National Lung Cancer Screening Trial showed low-dose lung CT screening was more efficacious in reducing deaths in high-risk individuals than conventional radiography. As such an ever-increasing number of health organizations now recommend this screening protocol. Lung Cancer Screening by Mark Parker and esteemed VCU Health colleagues fulfills the dire need for a comprehensive guide explaining the crucial aspects of lung cancer screenings. The first two chapters lay a foundation with discussion of lung cancer epidemiology and risk factors beyond cigarette smoking. Subsequent chapters cover the fundamentals with clinical pearls on setting up a successful lung cancer screening program patient eligibility criteria imaging variances of tumors in the lungs screening pros and cons and interpreting reporting screening results. - The evolution and future of lung cancer screenings - Detection and management of unexpected incidental pulmonary and non-pulmonary findings - Discussion of test cases utilizing the Lung-RADSTM risk-stratifying system for low-dose chest CT screenings - Benefits and potential harms associated with mass lung cancer screening programs including false positive false negative and over-diagnosis rates This state-of-the-art guide is essential reading for radiologists oncologists pulmonologists and internists. It is a must-have bookshelf reference for hospital radiology and oncology departments in particular for those setting up new lung cancer screening programs.

Produktinformationen zuletzt aktualisiert am
04.04.2025 um 21:56 Uhr

Produktzustand:

Verfügbarkeit:

Versandkosten:

Sonderpreis: